Logo Medical Science Monitor Basic Research

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Basic Research Logo Medical Science Monitor Basic Research Logo Medical Science Monitor Basic Research

07 November 2024 : Clinical Research  

Effect of Lidocaine on Ciprofol Dosage and Efficacy in Patients Who Underwent Gastroscopy Sedation

Yang Han1ABCDEF, Baohua Zhang1ABCD, Li Jin1ABC, Zhiyang Yu1ABC, Huan He2ABCDFG*

DOI: 10.12659/MSMBR.945751

Med Sci Monit Basic Res 2024; 30:e945751

Abstract

BACKGROUND: Intravenous ciprofol is a short-acting sedative with minimal respiratory and circulatory suppression and limited analgesia. Intravenous lidocaine provides analgesia during surgical procedures. This study included 70 patients who underwent gastroscopy with analgesia and aimed to evaluate the effects of intravenous lidocaine on the dose of ciprofol required to produce 50% of the maximal effect (ED50).

MATERIAL AND METHODS: Seventy patients scheduled for elective painless gastroscopy were randomly assigned into 2 groups: group L (n=35, received ciprofol and 1.5 mg/kg lidocaine) and group S (n=35, received ciprofol and normal saline). The primary outcomes measured were the ED50 and the 95% effective dose (ED95) of ciprofol, determined using the modified up-down sequential method and Probit analysis. Secondary outcomes included induction, operation, and recovery times; monitoring of vital signs such as mean arterial pressure, heart rate, and oxygen saturation; and evaluation of postoperative adverse reactions, including sore throat, nausea, vomiting, abdominal pain, and satisfaction scores from endoscopists and anesthesiologists.

RESULTS: The ED50 of ciprofol in group L was 0.315 mg/kg (95% CI, 0.291-0.342 mg/kg), which was significantly lower than that in group S, 0.42 mg/kg (95% CI, 0.371-0.491 mg/kg). Additionally, group L exhibited shorter induction and recovery times, a lower incidence of postoperative sore throat, and a temporary drop in blood pressure following induction.

CONCLUSIONS: Intravenous lidocaine during painless gastroscopy reduces the required ciprofol dose, shortens induction and recovery times, and lowers the incidence of postoperative complications, such as sore throat. These findings support its effective role in improving sedation quality and patient outcomes during gastroscopy.

Keywords: Lidocaine, Ciprofol, Painless Gastroscope, ED50, Humans, Male, Female, Gastroscopy, Middle Aged, adult, Hypnotics and Sedatives, Aged, Dose-Response Relationship, Drug, Conscious Sedation, Anesthetics, Local, Cyclopropanes

Add Comment 0 Comments

Most Viewed Current Articles

13 Apr 2020 : Original article   19,586

Outcome of 24 Weeks of Combined Schroth and Pilates Exercises on Cobb Angle, Angle of Trunk Rotation, Chest...

DOI :10.12659/MSMBR.920449

Med Sci Monit Basic Res 2020; 26:e920449

20 Apr 2018 : Original article   17,466

Brain Training Games Enhance Cognitive Function in Healthy Subjects

DOI :10.12659/MSMBR.909022

Med Sci Monit Basic Res 2018; 24:63-69

23 Jul 2016 : Review article   10,353

Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis

DOI :10.12659/MSMBR.900437

Med Sci Monit Basic Res 2016; 22:75-79

10 Aug 2020 : Clinical Research   9,788

Effects of Cognitive Task Training on Dynamic Balance and Gait of Patients with Stroke: A Preliminary Rando...

DOI :10.12659/MSMBR.925264

Med Sci Monit Basic Res 2020; 26:e925264

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor Basic Research eISSN: 2325-4416
Medical Science Monitor Basic Research eISSN: 2325-4416